Daiming Fan

Author PubWeight™ 327.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008 4.09
2 MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009 3.66
3 MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010 3.12
4 Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009 2.86
5 Hepatitis B in China. Lancet 2007 2.67
6 Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2009 2.37
7 Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008 2.28
8 How to solve the crisis behind Bribegate for Chinese doctors. Lancet 2011 2.27
9 Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2013 2.22
10 Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2010 2.11
11 Telephone-based re-education on the day before colonoscopy improves the quality of bowel preparation and the polyp detection rate: a prospective, colonoscopist-blinded, randomised, controlled study. Gut 2013 1.97
12 MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 2010 1.80
13 Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010 1.79
14 Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011 1.68
15 Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol 2007 1.66
16 Find duplicates among the PubMed, EMBASE, and Cochrane Library Databases in systematic review. PLoS One 2013 1.63
17 Prevalence of covert duplicate publications in Budd-Chiari syndrome articles in China: a systematic analysis. Am J Med 2013 1.63
18 Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004 1.63
19 TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biol Ther 2006 1.57
20 Effect of a novel inhibitory mAb against beta-subunit of F1F0 ATPase on HCC. Cancer Biol Ther 2008 1.54
21 Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. Intern Emerg Med 2014 1.52
22 Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding. J Gastroenterol Hepatol 2012 1.51
23 Reversal of multidrug resistance of gastric cancer cells by downregulation of TSG101 with TSG101siRNA. Cancer Biol Ther 2004 1.51
24 MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011 1.51
25 Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome C release. Cancer Biol Ther 2009 1.50
26 Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 2013 1.50
27 Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol 2013 1.49
28 Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2007 1.48
29 MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2010 1.45
30 Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. Cancer Biol Ther 2004 1.44
31 Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature. Eur J Gastroenterol Hepatol 2015 1.43
32 Helicobacter pylori infection may improve the survival of patients with carcinomas. Med Hypotheses 2007 1.40
33 Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 2013 1.39
34 Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt. Hepatology 2010 1.39
35 Up-regulation of tumor suppressor genes might promote the malignant phenotype of cancer cells. Med Hypotheses 2007 1.39
36 Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015 1.33
37 MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 2011 1.30
38 Dysregulation of cellular signaling in gastric cancer. Cancer Lett 2010 1.29
39 The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010 1.28
40 MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 2013 1.25
41 Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006 1.23
42 Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J Hepatol 2012 1.22
43 Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med 2012 1.21
44 miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett 2013 1.21
45 Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One 2012 1.20
46 The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 2012 1.20
47 MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS One 2012 1.20
48 Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009 1.18
49 Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 2007 1.17
50 Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005 1.16
51 KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 2013 1.16
52 MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 2011 1.15
53 PALS1 specifies the localization of ezrin to the apical membrane of gastric parietal cells. J Biol Chem 2005 1.15
54 Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 2007 1.14
55 Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 2010 1.14
56 Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion 2011 1.13
57 Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 2007 1.13
58 Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 2012 1.12
59 Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 2012 1.12
60 Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res 2004 1.12
61 Brivanib for hepatocellular carcinoma trials: selection bias from barcelona clinic liver cancer stage? J Clin Oncol 2014 1.10
62 Hepatopulmonary Syndrome. Dig Dis Sci 2015 1.10
63 Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 2010 1.10
64 Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 2010 1.09
65 Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med 2009 1.08
66 Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 2004 1.08
67 Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002 1.08
68 MicroRNA-21: a therapeutic target for reversing drug resistance in cancer. Expert Opin Ther Targets 2013 1.07
69 Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer. Biochem Biophys Res Commun 2005 1.07
70 The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein. Dig Dis Sci 2008 1.07
71 Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol 2013 1.07
72 MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells. J Cell Sci 2013 1.06
73 Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. FASEB J 2013 1.06
74 Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013 1.06
75 Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. Carcinogenesis 2008 1.05
76 Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007 1.05
77 Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Lett 2010 1.04
78 Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem 2008 1.04
79 Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia 2006 1.03
80 Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J Histochem Cytochem 2008 1.02
81 Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line. J Cell Biochem 2012 1.02
82 IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J Cell Biochem 2002 1.02
83 In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS One 2013 1.02
84 New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol 2010 1.02
85 Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Gastric Cancer 2004 1.01
86 Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci 2009 1.01
87 Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression. PLoS One 2012 1.00
88 I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population. Hepatology 2011 1.00
89 Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist Updat 2010 1.00
90 Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011 1.00
91 Akt1/protein kinase B alpha is involved in gastric cancer progression and cell proliferation. Dig Dis Sci 2008 0.99
92 Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology 2006 0.99
93 Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells. Autophagy 2010 0.98
94 p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res 2007 0.98
95 Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol 2007 0.97
96 RhoC is essential for the metastasis of gastric cancer. J Mol Med (Berl) 2007 0.97
97 MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun 2012 0.96
98 Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci 2011 0.96
99 Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem Biophys Res Commun 2011 0.96
100 Hypoxia induced overexpression of PrP(C) in gastric cancer cell lines. Cancer Biol Ther 2007 0.96
101 Establishment and characterization of calcyclin binding protein (CacyBP) monoclonal antibody. Hybridoma (Larchmt) 2006 0.96
102 Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 2011 0.96
103 CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 2008 0.95
104 Retracted EpCAM: a potential antimetastatic target for gastric cancer. Dig Dis Sci 2009 0.94
105 ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer. Int J Cancer 2010 0.94
106 Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 2011 0.94
107 Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PLoS One 2011 0.94
108 p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 2007 0.94
109 Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS J 2009 0.94
110 CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther 2006 0.94
111 Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology 2008 0.94
112 Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis. Int J Cancer 2009 0.93
113 Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 2008 0.93
114 Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 2009 0.93
115 Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem 2012 0.93
116 MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer. Am J Clin Pathol 2009 0.92
117 Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer. Cancer Invest 2008 0.92
118 Expression and significances of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett 2004 0.92
119 Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol Ther 2005 0.92
120 Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol 2010 0.92
121 A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy. BMC Cell Biol 2009 0.92
122 Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. Biochem Biophys Res Commun 2004 0.91
123 Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med 2014 0.91
124 Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull 2009 0.91
125 Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. Mol Genet Genomics 2014 0.91
126 Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1. Int J Cancer 2011 0.90
127 Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer Biol Ther 2005 0.90
128 Prevalence of thrombotic risk factors in Chinese Budd-Chiari syndrome patients: results of a prospective validation study. Eur J Gastroenterol Hepatol 2014 0.90
129 CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol Carcinog 2011 0.90
130 The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer. BMC Cancer 2014 0.90
131 Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients. J Gastroenterol Hepatol 2013 0.90
132 A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract. Int J Med Sci 2013 0.90
133 Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-κB pathway. J Immunol 2011 0.90
134 Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells. J Cell Biochem 2004 0.90
135 Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma. Cancer Biol Ther 2012 0.89
136 CIAPIN1 as a therapeutic target in cancer. Expert Opin Ther Targets 2010 0.89
137 Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review. Asia Pac J Clin Oncol 2013 0.89
138 Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC. J Control Release 2008 0.89
139 Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells. Mol Cell Biochem 2007 0.89
140 Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis. J Cancer Res Clin Oncol 2008 0.89
141 URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway. J Cell Mol Med 2008 0.89
142 Mechanisms of growth arrest by zinc ribbon domain-containing 1 in gastric cancer cells. Carcinogenesis 2007 0.89
143 Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest 2009 0.89
144 Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K. Mol Cancer 2012 0.89
145 CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27. Cancer Biol Ther 2007 0.89
146 Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential. Biochem Biophys Res Commun 2006 0.89
147 Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochem Biophys Res Commun 2010 0.88
148 Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 2005 0.88
149 Stage of portal vein thrombosis. J Hepatol 2010 0.88
150 Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma. Biochem Biophys Res Commun 2007 0.88
151 Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 2005 0.88
152 EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinoma. Clin Cancer Res 2014 0.88
153 Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials. J Clin Gastroenterol 2014 0.88
154 Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. J Mol Med (Berl) 2006 0.87
155 Degree of portal vein thrombosis. Hepatology 2010 0.87
156 Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies. Hepatol Res 2014 0.87
157 Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp Cell Res 2005 0.87
158 Water exchange enhanced cecal intubation in potentially difficult colonoscopy. Unsedated patients with prior abdominal or pelvic surgery: a prospective, randomized, controlled trial. Gastrointest Endosc 2013 0.87
159 Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene. Biochem Biophys Res Commun 2004 0.87
160 Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1). J Cell Mol Med 2011 0.87
161 Anticoagulation for portal vein thrombosis in cirrhosis. Am J Med 2010 0.87
162 The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China. Vaccine 2012 0.87
163 Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Mol Carcinog 2009 0.87
164 Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO. Biochem Biophys Res Commun 2003 0.87
165 MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation. J Cancer Res Clin Oncol 2014 0.87
166 A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem Cell Biol 2007 0.87
167 Upregulation of PPARgamma in tissue with gastric carcinoma. Hybridoma (Larchmt) 2010 0.86
168 The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells. Cancer Biol Ther 2004 0.86
169 RhoE is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol 2012 0.86
170 Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxia-inducible-factor 1-dependent mechanism and contributes to drug resistance. Int J Cancer 2009 0.86
171 Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cells. PLoS One 2012 0.86
172 Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinoma. Cell Physiol Biochem 2014 0.86
173 Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol 2014 0.86
174 A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Amino Acids 2011 0.86
175 MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 2002 0.86
176 Growth arrest-specific gene 1 is downregulated and inhibits tumor growth in gastric cancer. FEBS J 2012 0.86
177 Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. J Biol Chem 2009 0.86
178 Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker. Cancer Lett 2008 0.85
179 Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol 2011 0.85
180 Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA. World J Surg Oncol 2011 0.85
181 Peripheral blood monocytes from the decompensated liver cirrhosis could migrate into nude mouse liver with human hepatocyte-markers expression. Biochem Biophys Res Commun 2008 0.85
182 Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Dig Dis Sci 2007 0.85
183 Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer. Oncotarget 2014 0.85
184 Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins. Biochem Biophys Res Commun 2013 0.85
185 MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. BMC Cancer 2014 0.85
186 Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. J Gene Med 2010 0.85
187 High Ran level is correlated with poor prognosis in patients with colorectal cancer. Int J Clin Oncol 2012 0.84
188 CT features of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol 2012 0.84
189 Cell tracing techniques in stem cell transplantation. Stem Cell Rev 2007 0.84
190 Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res 2012 0.84
191 Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran. Antioxid Redox Signal 2013 0.84
192 Drug resistance-related miRNAs in hepatocellular cancer. Expert Rev Gastroenterol Hepatol 2014 0.84
193 Overview of mimotopes and related strategies in tumor vaccine development. Expert Rev Vaccines 2008 0.84
194 Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32. Cell Biol Int 2007 0.84
195 Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Mol Imaging Biol 2012 0.84
196 Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochem Biophys Res Commun 2006 0.84
197 Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis. Genet Test Mol Biomarkers 2012 0.84
198 Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer 2006 0.84
199 R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction. Mol Pharm 2010 0.83
200 Preparation and characterization of a specific monoclonal antibody against CIAPIN1. Hybridoma (Larchmt) 2005 0.83
201 Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res 2013 0.83
202 Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006). J Cancer Res Clin Oncol 2007 0.83
203 The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. J Exp Clin Cancer Res 2011 0.83
204 Distribution of CIAPIN1 in normal fetal and adult human tissues. J Histochem Cytochem 2005 0.83
205 DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1. Cancer Invest 2007 0.83
206 Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis. Helicobacter 2007 0.83
207 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer. Cancer Biol Ther 2010 0.83
208 Enhanced immune response to gastric cancer specific antigen Peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion. Cancer Biol Ther 2005 0.83
209 Subcellular localization of CIAPIN1. J Histochem Cytochem 2006 0.83
210 Heat shock protein 72 protects kidney proximal tubule cells from injury induced by triptolide by means of activation of the MEK/ERK pathway. Int J Toxicol 2009 0.83
211 Epigenetic regulation of microRNAs in gastric cancer. Dig Dis Sci 2013 0.83
212 Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc Intervent Radiol 2014 0.82
213 Induction of T lymphocytes specific to human gastric cancer using HLA-A matched allogeneic gastric tumor cells. J Immunother 2003 0.82
214 Regulation of multidrug resistance by MGr1-antigen in gastric cancer cells. Tumour Biol 2005 0.82
215 Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells. Cancer Invest 2009 0.82
216 A novel DNA vaccine containing four mimicry epitopes for gastric cancer. Cancer Biol Ther 2005 0.82
217 Mesenchymal stem cells promote epithelial to mesenchymal transition and metastasis in gastric cancer though paracrine cues and close physical contact. J Cell Biochem 2015 0.82
218 Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011 0.82
219 In-depth research of multidrug resistance related cell surface glycoproteome in gastric cancer. J Proteomics 2013 0.82
220 ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005 0.82
221 Function of miRNA in controlling drug resistance of human cancers. Curr Drug Targets 2013 0.82
222 URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin. Biochem Biophys Res Commun 2009 0.82
223 Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. Helicobacter 2012 0.82
224 RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 2008 0.82
225 Serum cytokeratin-18 fragment level: a noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis. Hepatology 2010 0.81
226 Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression. Cancer Biol Ther 2009 0.81
227 Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Hepatology 2009 0.81
228 High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2015 0.81
229 The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. Cytotherapy 2010 0.81
230 The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology 2010 0.81
231 Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer. Proteomics 2008 0.81
232 Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer. Mol Cancer 2014 0.81
233 Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012 0.81
234 The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther 2010 0.81
235 Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis. J Clin Gastroenterol 2015 0.81
236 Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2014 0.81
237 Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells. Cell Biol Int 2007 0.81
238 The significance of LRPPRC overexpression in gastric cancer. Med Oncol 2013 0.81
239 Reversal of multidrug resistance of adriamycin-resistant gastric adenocarcinoma cells through the up-regulation of DARPP-32. Dig Dis Sci 2007 0.80
240 The value of MG7-Ag and COX-2 for predicting malignancy in gastric precancerous lesions. Cell Biol Int 2010 0.80
241 RUNX3 inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin. Cancer Biol Ther 2008 0.80
242 Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening. Int J Cancer 2010 0.80
243 Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp. Cancer Biol Ther 2008 0.80
244 Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2. J Proteomics 2013 0.80
245 Detection of gastric carcinoma-associated antigen MG7-Ag in human sera using surface plasmon resonance sensor. Cancer Epidemiol 2010 0.80
246 Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation. Dig Dis Sci 2012 0.80
247 Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma. Int J Cancer 2010 0.80
248 Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013 0.80
249 Left-colon water exchange preserves the benefits of whole colon water exchange at reduced cecal intubation time conferring significant advantage in diagnostic colonoscopy - a prospective, randomized controlled trial. Scand J Gastroenterol 2015 0.79
250 IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese. BMC Gastroenterol 2010 0.79
251 RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4. PLoS One 2013 0.79
252 ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem Cell Biol 2006 0.79
253 [Effect of human calcyclin binding protein encoding gene on development of multiple drug resistance in gastric cancer]. Zhonghua Zhong Liu Za Zhi 2002 0.79
254 l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2013 0.79
255 Small interfering RNA: a new tool for gene therapy. Curr Gene Ther 2003 0.79
256 Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol 2015 0.79
257 MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance. Expert Opin Biol Ther 2014 0.79
258 IκBα polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sci 2011 0.79
259 Inhibition of osteopontin would suppress angiogenesis in gastric cancer. Biochem Cell Biol 2007 0.79
260 Decreased expression of FOXJ1 is a potential prognostic predictor for progression and poor survival of gastric cancer. Ann Surg Oncol 2014 0.79
261 Function of PrPC (1-OPRD) in biological activities of gastric cancer cell lines. J Cell Mol Med 2009 0.79
262 Preparation and characterization of a specific monoclonal antibody against a new gene product: URG11. Hybridoma (Larchmt) 2006 0.79
263 [Delayed rectifier K(+) channel regulated by cyclooxygenase-2 in human gastric cancer cell]. Zhonghua Zhong Liu Za Zhi 2002 0.79
264 Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2016 0.79
265 Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma. Hepatology 2012 0.79
266 Successful expression and purification of human CIAPIN1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity. Int J Biol Macromol 2007 0.79
267 Clinicopathological features and prognosis of coexistence of gastric gastrointestinal stromal tumor and gastric cancer. Medicine (Baltimore) 2016 0.78
268 Immunological basis of stem cell therapy in liver diseases. Expert Rev Clin Immunol 2014 0.78
269 Prognosis-related microRNAs in esophageal cancer. Expert Opin Biol Ther 2014 0.78
270 RUNX3 mediates suppression of tumor growth and metastasis of human CCRCC by regulating cyclin related proteins and TIMP-1. PLoS One 2012 0.78
271 Expression, purification, and characterization of recombinant protein GX1-rmhTNFalpha. Mol Biotechnol 2009 0.78
272 Cavernous vessels around a patent portal trunk in the liver hilum. Abdom Imaging 2012 0.78
273 Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. Dig Dis Sci 2008 0.78
274 Drug resistance-related microRNAs in esophageal cancer. Expert Opin Biol Ther 2012 0.78
275 Inhibitory effect of recombinant adenovirus carrying immunocaspase-3 on hepatocellular carcinoma. Biochem Biophys Res Commun 2007 0.78
276 [Local cytokines profile in gastric cancer lesions]. Zhonghua Zhong Liu Za Zhi 2002 0.78
277 Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) 2015 0.78
278 Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes. Tumour Biol 2013 0.78
279 Effect of CO2 cholangiography on post-ERCP cholangitis in patients with unresectable malignant hilar obstruction - a prospective, randomized controlled study. Scand J Gastroenterol 2013 0.78
280 Prognostic markers in esophageal cancer: from basic research to clinical use. Expert Rev Gastroenterol Hepatol 2015 0.78
281 Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge. Carbohydr Polym 2012 0.78
282 Angiogenesis-related molecular targets in esophageal cancer. Expert Opin Investig Drugs 2011 0.78
283 Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J Mol Med (Berl) 2006 0.77
284 Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series. Medicine (Baltimore) 2016 0.77
285 Scientific publications on systematic review and meta-analysis from Chinese authors: a 10-year survey of the English literature. Front Med 2012 0.77
286 Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis. Gene 2012 0.77
287 Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression. J Clin Invest 2015 0.77
288 Stem cell associated genes working with one miRNA cluster have different clinic pathologic values in gastric cancer. Pathol Oncol Res 2011 0.77
289 Retracted RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer. Cancer Biol Ther 2009 0.77
290 SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma. PLoS One 2013 0.77
291 Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett 2005 0.77
292 Degree of portal vein thrombosis might be associated with recanalization during anticoagulation. Clin Gastroenterol Hepatol 2012 0.77
293 Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. Chin Med J (Engl) 2002 0.77
294 Monoclonal antibody MG7 as a screening tool for gastric cancer. Hybridoma (Larchmt) 2010 0.77
295 Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. J Biol Chem 2012 0.77
296 Inhibition of gastric cancer angiogenesis by vector-based RNA interference for Raf-1. Cancer Biol Ther 2005 0.77
297 A large portal vein: a rare finding of recent portal vein thrombosis. Case Rep Gastroenterol 2011 0.77
298 Targeting viral dsRNA for antiviral prophylaxis. FASEB J 2009 0.77
299 Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Hepatology 2009 0.77
300 Preparation and characterization of a novel monoclonal antibody specific to human ZNRD1 protein. Hybrid Hybridomics 2004 0.77
301 KCl depolarization increases HIF-1 transcriptional activity via the calcium-independent pathway in SGC7901 gastric cancer cells. Tumour Biol 2007 0.77
302 [In situ hybridization of tight junction molecule occludin mRNA in gastric cancer]. Zhonghua Zhong Liu Za Zhi 2002 0.77
303 Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013 0.76
304 [Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system]. Zhonghua Gan Zang Bing Za Zhi 2002 0.76
305 COX2-related multicentric mixed-type Castleman's disease in a young man. Nat Clin Pract Oncol 2005 0.76
306 Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins. J Proteome Res 2014 0.76
307 Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells. Life Sci 2005 0.76
308 [Clinical application of molecular adsorbent recirculating system-artificial liver support system]. Zhonghua Gan Zang Bing Za Zhi 2002 0.76
309 A retrospective analysis on the diagnostic value of ultrasound-guided percutaneous biopsy for peritoneal lesions. World J Surg Oncol 2013 0.76
310 Coronary heart disease in type 2 diabetes: mechanisms and comprehensive prevention strategies. Expert Rev Cardiovasc Ther 2012 0.75
311 Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors. Medicine (Baltimore) 2016 0.75
312 A confusing relationship between Child-Turcotte-Pugh class A and compensated cirrhosis. Am J Gastroenterol 2010 0.75
313 Insulin resistance and platelet count/spleen diameter ratio: two simple, easy-to-get tests for predicting esophageal varices in cirrhosis. Hepatology 2009 0.75
314 Do EASL and mRECIST responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization? J Hepatol 2012 0.75
315 Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat? Radiology 2013 0.75
316 Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: still an open issue. Liver Int 2014 0.75
317 Meta-analysis: the relationship between TNF-alpha polymorphisms and susceptibility to primary biliary cirrhosis. Hepatogastroenterology 2013 0.75
318 Anticoagulation and variceal bleeding in non-cirrhotic patients with portal vein thrombosis. Intern Emerg Med 2010 0.75
319 Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore) 2017 0.75
320 Coagulopathy of chronic liver disease. N Engl J Med 2011 0.75
321 Drawing conclusions about short-term variability in liver function test results. Ann Intern Med 2008 0.75
322 RNA interference: a new therapeutic strategy of cancer. Cancer Biol Ther 2005 0.75
323 Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension? Liver Int 2012 0.75
324 Letter by Hong et al regarding article, "Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation". Circulation 2008 0.75
325 What is the relationship between epidermal growth factor-like domain 7 and RhoC in metastasis of hepatocellular carcinoma? Hepatology 2010 0.75
326 Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide. Biochem Cell Biol 2012 0.75
327 Sildenafil as treatment for antidepressant-induced sexual dysfunction. JAMA 2008 0.75
328 Monitoring cholesterol levels: understanding variance and finding the most useful data. Ann Intern Med 2008 0.75
329 Survivin, the promising target in hepatocellular carcinoma gene therapy. Cancer Biol Ther 2008 0.75
330 Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig Dis Sci 2010 0.75
331 Effect of Testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women. Ann Intern Med 2008 0.75
332 Universal insurance coverage and health care inequity. Ann Intern Med 2009 0.75
333 Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis. Gut 2011 0.75
334 Large hepatic angiomyolipoma. Clin Res Hepatol Gastroenterol 2013 0.75
335 [Experimental study of multidrug resistance mediated by human laminin receptor in gastric cancer cells]. Zhonghua Yi Xue Za Zhi 2002 0.75
336 [The explanation of Holistic Integrative Medicine in theory]. Zhonghua Yi Xue Za Zhi 2016 0.75
337 Pancreatic Gastrointestinal Stromal Tumor: Clinicopathologic Features and Prognosis. J Clin Gastroenterol 2016 0.75
338 [Development of oral DNA vaccine based on MG(7)-Ag mimotope of gastric cancer]. Zhonghua Zhong Liu Za Zhi 2002 0.75
339 Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology Combined With Automated Quantitative DNA Cytometry Can Improve the Value in the Detection of Pancreatic Malignancy. Pancreas 2017 0.75
340 Expanded T cell clones and cytokines expression in human gastric carcinomas of different histological types. Zhonghua Bing Li Xue Za Zhi 2002 0.75
341 Monoclonal antibodies MC3 and MC5 can be used as a tool for screening colorectal cancer. Hybridoma (Larchmt) 2010 0.75
342 [The effects of C2 gene on growth of gastric cancer cells]. Zhonghua Nei Ke Za Zhi 2002 0.75
343 Education and imaging. Hepatobiliary and pancreatic: hepatosplenic gamma-delta T-cell lymphoma. J Gastroenterol Hepatol 2012 0.75
344 Cancer mucosa antigens: novel immunotherapeutic targets. Expert Opin Ther Targets 2008 0.75
345 [Holistic integrative hepatology]. Zhonghua Gan Zang Bing Za Zhi 2015 0.75
346 Education and Imaging. Hepatobiliary and pancreatic: Budd-Chiari syndrome with infra-hepatic obstruction of inferior vena cava. J Gastroenterol Hepatol 2013 0.75
347 Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study. Front Med 2012 0.75
348 [Expression of cytokine-induced apoptosis inhibitor 1 in gastric cancer tissues and its effects on invasion and migration of SGC-7901 cell]. Zhonghua Wei Chang Wai Ke Za Zhi 2015 0.75
349 Expression of MG7-Ag in patients with gastric cancer correlates with weaker T cell immune response and more proinflammatory cytokine secretion. Biochem Cell Biol 2006 0.75
350 Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs. Thromb Haemost 2015 0.75
351 New monoclonal antibody B7 selectively recognizes rat myocardium microvascular endothelial cells. Hybridoma (Larchmt) 2010 0.75
352 Splenic artery aneurysm. Clin Res Hepatol Gastroenterol 2012 0.75
353 Extrahepatic portal vein aneurysm. Clin Res Hepatol Gastroenterol 2012 0.75
354 Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children. J Pediatr Gastroenterol Nutr 2016 0.75
355 Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets 2017 0.75
356 Management of postoperative Crohn's disease. Expert Rev Gastroenterol Hepatol 2014 0.75
357 [Antisense inhibition of cyclooxygenase-2 reduces malignant phenotype of gastric cancer cells]. Zhonghua Nei Ke Za Zhi 2002 0.75
358 Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Ann Surg Oncol 2007 0.75
359 Preparation and characterization of four novel monoclonal antibodies specific to N51(L6)C46 polypeptide simulating fusogenic core structure of GP41 subunit of HIV-1. Hybridoma (Larchmt) 2006 0.75
360 Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design. Oncol Rep 2013 0.75
361 Reversal effect of electroacupuncture on the symptom of intractable hiccups in hepatitis B virus carriers. J Pain Symptom Manage 2008 0.75
362 MG7 mimotope-based DNA vaccination for gastric cancer. Expert Rev Vaccines 2006 0.75